perlmutter iv glutathione parkinson's video Disease-modifying, multidimensional efficacy of putaminal CaV1.3-shRNA gene therapy in aged parkinsonism male and female macaques Development of an α-synuclein positron
Development of an synuclein positron emission tomography tracer for imaging synucleinopathies ScienceDirect Mapping energy metabolism systems in the human brain bioRxiv Parkinson's Glutathione Therapy Dr David Perlmutter, MD FACN Central nervous system uptake of intranasal glutathione in Parkinson's disease npj Parkinson's Disease Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer's Disease: Finding Potential Therapeutic Targets Increased expression or activation of TRPML1 reduces hepatic storage of toxic Z alpha 1 antitrypsin: Molecular Therapy
Pay in 4 interest-free payments of $7.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





